Guardian Capital (Canada)’s Elevance Health ELV Stock Holding History

Guardian Capital (Canada)’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-1,354	Closed	-$382K	–	169
2019 Q2	$382K	Sell	1,354 -489	-27%	-$134K	0.01%	144
2019 Q1	$529K	Buy	+1,843	New	+$533K	0.01%	129
2015 Q2	–	Sell	-2,335	Closed	-$361K	–	218
2015 Q1	$361K	Sell	2,335 -340	-13%	-$48.4K	0.01%	189
2014 Q4	$336K	Buy	+2,675	New	+$331K	0.01%	204
2014 Q3	–	Sell	-9,789	Closed	-$1.05M	–	214
2014 Q2	$1.05M	Buy	+9,789	New	+$1.01M	0.02%	135
2014 Q1	–	Sell	-6,581	Closed	-$608K	–	207
2013 Q4	$608K	Buy	+6,581	New	+$585K	0.01%	158

Other funds holding ELV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

TCI Fund Management London, United Kingdom $52.8B AUM 12.71% 1-Year Est. Return

Guardian Capital (Canada)'s ELV Position: Q3 2019 in Review

Guardian Capital (Canada) sold out of Elevance Health (ELV) in Q3 2019, closing a stake of 1,354 shares — an estimated $382K sold.

Guardian Capital (Canada) first reported a position in ELV in Q4 2013 and held it in 6 quarters. The position peaked at $1.05M in Q2 2014. 1,016 funds tracked by Wall St. Rank hold ELV as of Q3 2019.

Guardian Capital (Canada) reported no remaining Elevance Health position as of Q3 2019 after selling out during the quarter.
Guardian Capital (Canada) sold 1,354 Elevance Health shares in Q3 2019, an estimated $382K.
Guardian Capital (Canada) first reported a position in Elevance Health in Q4 2013 and held it in 6 quarters.
Guardian Capital (Canada)'s Elevance Health position peaked at $1.05M in Q2 2014.
1,016 funds tracked by Wall St. Rank held Elevance Health as of Q3 2019.

Based on Guardian Capital (Canada)'s 13F filing for Q3 2019, filed 14 Nov 2019.